The findings could transform how doctors treat some of the sickest patients with chronic kidney disease, which affects more than one in seven adults in the United States but has no cure.
Diabetes is a leading cause of chronic kidney disease, which occurs when the kidneys don't function as well as they should.
The study included 3,533 people with kidney disease and Type 2 diabetes, about half of whom took a weekly injection of semaglutide, and half of whom took a weekly placebo shot.
[
add
]
[
|
|
...
]